Skip to main content
. Author manuscript; available in PMC: 2023 Feb 21.
Published in final edited form as: Genet Med. 2022 Mar 26;24(6):1187–1195. doi: 10.1016/j.gim.2022.02.016

Figure 1: Patient Selection.

Figure 1:

Figure depicts patients selection schema and demonstrates the number of cancer-affected and unaffected individuals as well as total pooled tumors and MMR-D/MSI status of tumors by ascertainment (MSK-IMPACT and LS registry cohort) and gene (MSH6 and PMS2)

Abbreviations: LS – Lynch Syndrome, MPC – Multiple primary cancer